Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000756498 | SCV000884329 | uncertain significance | not provided | 2017-05-16 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000756498 | SCV001815631 | likely benign | not provided | 2020-02-12 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 27567292) |
Ambry Genetics | RCV004027130 | SCV005005245 | likely benign | Inborn genetic diseases | 2024-02-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003965563 | SCV004778857 | benign | PKD1-related disorder | 2019-11-06 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |